Filter
Sort by
View
16 case(s) found.

Should Kazuria Produce Vaccines Locally with Unizima’s Support? Vaccine Manufacturing Capacity in Africa

By  Stephen E. Chick,  Luk Van Wassenhove,  Prashant Yadav,  Abed Kayyal
Add to cart new
New technological developments in biotechnology are creating new opportunities for less centralized production and distribution of biological medicines, including vaccines. This case explores how innovative small-scale production technologies in biotech enable more flexible production of vaccines and other biologic medicines in low- or middle-income countries (LMICs) and neighboring countries.

    Published 26 Jan 2024

    Reference 6850

    Length 19 page(s)

    Topic Operations

    Region Africa

    Industry Biotechnology

    View case

    Should Kazuria Produce Vaccines Locally with Unizima’s Support? Vaccine Manufacturing Capacity in Africa

    By  Stephen E. Chick,  Luk Van Wassenhove,  Prashant Yadav,  Abed Kayyal
    Add to cart new
    New technological developments in biotechnology are creating new opportunities for less centralized production and distribution of biological medicines, including vaccines. This case explores how innovative small-scale production technologies in biotech enable more flexible production of vaccines and other biologic medicines in low- or middle-income countries (LMICs) and neighboring countries.
      View case

      Integration Planning at SFB (A)

      By  Georgina Hall,  Piyush Gulati,  Anton S. Ovchinnikov
      Add to cart award extra
      Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.

        Published 15 Nov 2021

        Reference 6684

        Length 4 page(s)

        Topic Leadership & Organisations

        Region Europe

        Industry Biotechnology

        View case

        Integration Planning at SFB (A)

        By  Georgina Hall,  Piyush Gulati,  Anton S. Ovchinnikov
        Add to cart award extra
        Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
          View case

          Integration Planning at SFB (B)

          By  Georgina Hall,  Piyush Gulati,  Anton S. Ovchinnikov
          Add to cart award
          Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.

            Published 15 Nov 2021

            Reference 6684

            Length 2 page(s)

            Topic Leadership & Organisations

            Industry Biotechnology

            View case

            Integration Planning at SFB (B)

            By  Georgina Hall,  Piyush Gulati,  Anton S. Ovchinnikov
            Add to cart award
            Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
              View case

              Integration Planning at SFB (C)

              By  Georgina Hall,  Piyush Gulati,  Anton S. Ovchinnikov
              Add to cart award
              Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.

                Published 15 Nov 2021

                Reference 6684

                Length 2 page(s)

                Topic Leadership & Organisations

                Region Europe

                Industry Biotechnology

                View case

                Integration Planning at SFB (C)

                By  Georgina Hall,  Piyush Gulati,  Anton S. Ovchinnikov
                Add to cart award
                Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
                  View case

                  Praesens Care’s Mobile Laboratories: An Innovative Service for Diagnostic Testing in Africa

                  By  Luk Van Wassenhove,  Boas Meijer
                  Add to cart
                  Praesens Care, a start-up based in Belgium, has developed a mobile laboratory with the aim of safely testing people for a wide range of killer diseases. Its mobile laboratories enable monitoring of infectious diseases and improve diagnostic capabilities in remote areas in Africa.

                    Published 23 Mar 2021

                    Reference 6598

                    Length 8 page(s)

                    Topic Operations

                    Region Global

                    Industry Biotechnology

                    View case

                    Praesens Care’s Mobile Laboratories: An Innovative Service for Diagnostic Testing in Africa

                    By  Luk Van Wassenhove,  Boas Meijer
                    Add to cart
                    Praesens Care, a start-up based in Belgium, has developed a mobile laboratory with the aim of safely testing people for a wide range of killer diseases. Its mobile laboratories enable monitoring of infectious diseases and improve diagnostic capabilities in remote areas in Africa.
                      View case

                      Neighbours for Active Living: It Takes a Community to Maintain Health and Wellbeing of Seniors

                      By  Stephen E. Chick,  Ridhima Aggarwal
                      Add to cart
                      In 2013, Eastern Health Alliance (EHA) launched the Neighbours for Active Living programme to reduce hospital readmissions among seniors in eastern Singapore. At its core, ‘Neighbours’ addressed the health care and social needs of high-risk residents within their homes, while building social support systems around them through community outreach.

                        Published 27 Nov 2017

                        Reference 6336

                        Length 12 page(s)

                        Topic Operations

                        Region Asia

                        Industry Biotechnology

                        View case

                        Neighbours for Active Living: It Takes a Community to Maintain Health and Wellbeing of Seniors

                        By  Stephen E. Chick,  Ridhima Aggarwal
                        Add to cart
                        In 2013, Eastern Health Alliance (EHA) launched the Neighbours for Active Living programme to reduce hospital readmissions among seniors in eastern Singapore. At its core, ‘Neighbours’ addressed the health care and social needs of high-risk residents within their homes, while building social support systems around them through community outreach.
                          View case

                          Biotopia

                          By  Philip Anderson,  Sorah Seong
                          Add to cart Free Case
                          A Korean agricultural biotechnology company spun out from university research is at a crossroads. Using advanced fermentation technology, it has created a string of unique products for consumers and farmers. It now has an opportunity to license and develop a proprietary technology to solve a major social problem: odour from animal waste.

                            Published 26 Jun 2017

                            Reference 6309

                            Length 37 page(s)

                            Topic Entrepreneurship

                            Region Asia

                            Industry Biotechnology

                            View case

                            Biotopia

                            By  Philip Anderson,  Sorah Seong
                            Add to cart Free Case
                            A Korean agricultural biotechnology company spun out from university research is at a crossroads. Using advanced fermentation technology, it has created a string of unique products for consumers and farmers. It now has an opportunity to license and develop a proprietary technology to solve a major social problem: odour from animal waste.
                              View case

                              PatientsLikeMe: Using Social Network Health Data to Improve Patient Care

                              By  Stephen E. Chick,  Françoise Simon,  Ridhima Aggarwal
                              Add to cart popular
                              PatientsLikeMe, an online health community formed to provide value for patients in exchange for sharing their health data, had grown substantially since its founding in 2004. By 2016 it had over 130 employees. However, convincing investors of the viability of the business model proves more challenging.

                                Published 30 Jan 2017

                                Reference 6248

                                Length 18 page(s)

                                Topic Operations

                                Region North America

                                Industry Biotechnology

                                View case

                                PatientsLikeMe: Using Social Network Health Data to Improve Patient Care

                                By  Stephen E. Chick,  Françoise Simon,  Ridhima Aggarwal
                                Add to cart popular
                                PatientsLikeMe, an online health community formed to provide value for patients in exchange for sharing their health data, had grown substantially since its founding in 2004. By 2016 it had over 130 employees. However, convincing investors of the viability of the business model proves more challenging.
                                  View case

                                  Disrupting Dengue with an Emerging Markets Launch Strategy

                                  By  Stephen E. Chick,  Ridhima Aggarwal
                                  Add to cart popular
                                  Sanofi Pasteur’s newly approved dengue vaccine, Dengvaxia, was unusual in that it was launched in the Philippines and other at-risk countries. By choosing to “flip the model” – launch in an emerging market setting as opposed to developed markets – it had to overcome various obstacles across the value chain, from registration to financing to supply.

                                    Published 26 Sep 2016

                                    Reference 6212

                                    Length 22 page(s)

                                    Topic Operations

                                    Region Global

                                    Industry Biotechnology

                                    View case

                                    Disrupting Dengue with an Emerging Markets Launch Strategy

                                    By  Stephen E. Chick,  Ridhima Aggarwal
                                    Add to cart popular
                                    Sanofi Pasteur’s newly approved dengue vaccine, Dengvaxia, was unusual in that it was launched in the Philippines and other at-risk countries. By choosing to “flip the model” – launch in an emerging market setting as opposed to developed markets – it had to overcome various obstacles across the value chain, from registration to financing to supply.
                                      View case

                                      Double Vision: Making Eye Care Accessible through Cross-Subsidization

                                      By  Stephen E. Chick,  Ridhima Aggarwal
                                      Add to cart
                                      Facing reduced government funding, yet committed to broadening access to its services, Sankara Eye Care, a chain of hospitals in India, was at a crossroads in 2015. Over the years it had developed a lean operational model to provide free care to approximately 80 percent of its non-paying patients (cross-subsidized by paying patients).

                                        Published 24 Apr 2015

                                        Reference 6124

                                        Length 29 page(s)

                                        Topic Operations

                                        Region Asia

                                        Industry Biotechnology

                                        View case

                                        Double Vision: Making Eye Care Accessible through Cross-Subsidization

                                        By  Stephen E. Chick,  Ridhima Aggarwal
                                        Add to cart
                                        Facing reduced government funding, yet committed to broadening access to its services, Sankara Eye Care, a chain of hospitals in India, was at a crossroads in 2015. Over the years it had developed a lean operational model to provide free care to approximately 80 percent of its non-paying patients (cross-subsidized by paying patients).
                                          View case

                                          Reorganizing Healthcare Delivery through a Value-Based Approach

                                          By  Stephen E. Chick,  Ridhima Aggarwal
                                          Add to cart
                                          Set in 2014, this case study examines the development and ongoing transition to value- and outcomes-based commissioning for diabetes care across North Central London (NCL). With the aim of improving health outcomes among their local populations, Clinical Commissioning Groups (CCGs) in NCL set out to transform the delivery and funding of services.

                                            Published 23 Nov 2015

                                            Reference 6120

                                            Length 28 page(s)

                                            Topic Operations

                                            Region Europe

                                            Industry Biotechnology

                                            View case

                                            Reorganizing Healthcare Delivery through a Value-Based Approach

                                            By  Stephen E. Chick,  Ridhima Aggarwal
                                            Add to cart
                                            Set in 2014, this case study examines the development and ongoing transition to value- and outcomes-based commissioning for diabetes care across North Central London (NCL). With the aim of improving health outcomes among their local populations, Clinical Commissioning Groups (CCGs) in NCL set out to transform the delivery and funding of services.
                                              View case

                                              Singapore’s Economic Development Strategy and the Biomedical Sciences Cluster

                                              By  Jasjit Singh
                                              Add to cart
                                              Singapore's economic success has come from continually upgrading its business environment. To sustain this, the government is now nurturing knowledge-intensive clusters like biomedical sciences. However, Singapore remains over-dependent on foreign multinationals and talent, and efforts to boost local innovation and entrepreneurship have had mixed success. What should Singapore do next?

                                                Published 16 Dec 2011

                                                Reference 5838

                                                Length 11 page(s)

                                                Topic Economics & Finance

                                                Region Asia

                                                Industry Biotechnology

                                                View case

                                                Singapore’s Economic Development Strategy and the Biomedical Sciences Cluster

                                                By  Jasjit Singh
                                                Add to cart
                                                Singapore's economic success has come from continually upgrading its business environment. To sustain this, the government is now nurturing knowledge-intensive clusters like biomedical sciences. However, Singapore remains over-dependent on foreign multinationals and talent, and efforts to boost local innovation and entrepreneurship have had mixed success. What should Singapore do next?
                                                  View case